Notably, KMT9α overexpression was higher in lymph node metastases (58.3%, n = 7) than in primary CCA tissue (35.1%, n = 61), although this difference did not reach statistical significance ( p = 0.107) (Fig. 2 A).
← all excerpts
Overexpression of KMT9α is associated with poor outcome in cholangiocarcinoma patients.
1
0.1070
0.1070